H-1B sponsorship profile: Summit Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Summit Therapeutics, Inc filed 12 Labor Condition Applications covering 12 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 91.7% (11 certified of 12 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Summit Therapeutics, Inc’s H-1B petitions range from $110,000 at the low end to $210,000 at the high end, with a petition-weighted average of $161,672. That range reflects the mix of occupations the company sponsors, led by Senior Data Scientist (2 petitions at $170,750 avg), followed by Senior Regulatory Associate and Senior Manager/Associate Director - Oncology Market Planning. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Summit Therapeutics, Inc is headquartered in Menlo Park, CA under NAICS code 541714, and places H-1B workers across 4 states, most heavily in CA, NJ, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Summit Therapeutics, Inc ranks. By H-1B petition volume, Summit Therapeutics, Inc is #14,627 of 119,880 employers nationally and #2,274 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.